Monday 6 October 2014

Sunesis slumps after cancer drug fails late-stage trial

(Reuters) - Sunesis Pharmaceuticals Inc said its experimental cancer drug did not meet the main goal in a late-stage trial, sending the company's shares plunging 77 percent to their lowest in more than two years.


via Reuters: Health News Read More Here..

No comments:

Post a Comment